|
Originally published In Press as doi:10.1074/jbc.M601225200 on July 10, 2006
J. Biol. Chem., Vol. 281, Issue 37, 26932-26942, September 15, 2006
MicroRNA-9 Controls the Expression of Granuphilin/Slp4 and the Secretory Response of Insulin-producing Cells*
Valérie Plaisance ,
Amar Abderrahmani ,
Véronique Perret-Menoud ,
Patrick Jacquemin¶1,
Frédéric Lemaigre¶, and
Romano Regazzi 2
From the
Department of Cell Biology and Morphology, University of Lausanne, Rue de Bugnon 9, 1005 Lausanne, Switzerland, the Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, 1005 Lausanne, Switzerland, and the ¶Hormone and Metabolic Research Unit, Université catholique de Louvain, Institute of Cellular Pathology, 1200 Brussels, Belgium
Insulin release from pancreatic -cells plays an essential role in blood glucose homeostasis. Several proteins controlling insulin exocytosis have been identified, but the factors determining the expression of the components of the secretory machinery of -cells remain largely unknown. MicroRNAs are newly discovered small non-coding RNAs acting as repressors of gene expression. We found that overexpression of mir-9 in insulin-secreting cells causes a reduction in exocytosis elicited by glucose or potassium. We show that mir-9 acts by diminishing the expression of the transcription factor Onecut-2 and, in turn, by increasing the level of Granuphilin/Slp4, a Rab GTPase effector associated with -cell secretory granules that exerts a negative control on insulin release. Indeed, electrophoretic mobility shift assays, chromatin immunoprecipitation, and transfection experiments demonstrated that Onecut-2 is able to bind to the granuphilin promoter and to repress its transcriptional activity. Moreover, we show that silencing of Onecut-2 by RNA interference increases Granuphilin expression and mimics the effect of mir-9 on stimulus-induced exocytosis. Our data provide evidence that in insulin-producing cells adequate levels of mir-9 are mandatory for maintaining appropriate Granuphilin levels and optimal secretory capacity.
Received for publication, February 8, 2006
, and in revised form, June 12, 2006.
* This work was supported in part by the Swiss National Foundation (Grant 3100A0-105425 to A. A. and Grant 3200B0-101746 to R. R.), Alfediam-Takeda (to V. P.), the Belgian State Program on Interuniversity Poles of Attraction, the French Community of Belgium, and the Belgian Fund for Scientific Medical Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Research Associate of the National Fund for Scientific Research (Belgium).
2 To whom correspondence should be addressed: Dept. of Cell Biology and Morphology, Rue du Bugnon 9, 1005 Lausanne, Switzerland. Tel.: 41-21-692-5280; Fax: 41-21-692-5255; E-mail: Romano.Regazzi{at}unil.ch.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Kato, L. Arce, and R. Natarajan
MicroRNAs and Their Role in Progressive Kidney Diseases
Clin. J. Am. Soc. Nephrol.,
July 1, 2009;
4(7):
1255 - 1266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Muhonen and H. Holthofer
Epigenetic and microRNA-mediated regulation in diabetes
Nephrol. Dial. Transplant.,
April 1, 2009;
24(4):
1088 - 1096.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bazzoni, M. Rossato, M. Fabbri, D. Gaudiosi, M. Mirolo, L. Mori, N. Tamassia, A. Mantovani, M. A. Cassatella, and M. Locati
Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals
PNAS,
March 31, 2009;
106(13):
5282 - 5287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. El Ouaamari, N. Baroukh, G. A. Martens, P. Lebrun, D. Pipeleers, and E. van Obberghen
miR-375 Targets 3'-Phosphoinositide-Dependent Protein Kinase-1 and Regulates Glucose-Induced Biological Responses in Pancreatic {beta}-Cells
Diabetes,
October 1, 2008;
57(10):
2708 - 2717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lovis, E. Roggli, D. R. Laybutt, S. Gattesco, J.-Y. Yang, C. Widmann, A. Abderrahmani, and R. Regazzi
Alterations in MicroRNA Expression Contribute to Fatty Acid-Induced Pancreatic {beta}-Cell Dysfunction
Diabetes,
October 1, 2008;
57(10):
2728 - 2736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Perry, S. A. Moschos, A. E. Williams, N. J. Shepherd, H. M. Larner-Svensson, and M. A. Lindsay
Rapid Changes in MicroRNA-146a Expression Negatively Regulate the IL-1{beta}-Induced Inflammatory Response in Human Lung Alveolar Epithelial Cells
J. Immunol.,
April 15, 2008;
180(8):
5689 - 5698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Tang, J. Gal, X. Zhuang, W. Wang, H. Zhu, and G. Tang
A simple array platform for microRNA analysis and its application in mouse tissues
RNA,
October 1, 2007;
13(10):
1803 - 1822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Baroukh, M. A. Ravier, M. K. Loder, E. V. Hill, A. Bounacer, R. Scharfmann, G. A. Rutter, and E. Van Obberghen
MicroRNA-124a Regulates Foxa2 Expression and Intracellular Signaling in Pancreatic {beta}-Cell Lines
J. Biol. Chem.,
July 6, 2007;
282(27):
19575 - 19588.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|